Parmax Pharma Ltd

₹ 59.3 4.99%

12 Jun - close price

About

Incorporated in 1994, Parmax Pharma Ltd manufactures Bulk Drugs, Drug Intermediates & Speciality Chemicals.^[1]

Key Points

Business Overview:^[1]
PPL is engaged in the manufacture and supply
of bulk drugs (APIs) and selected formulations
catering primarily to the Indian pharma industry.

Website BSE

Market Cap ₹ 22.2 Cr.
Current Price ₹ 59.3
High / Low ₹ 59.3 / 22.6
Stock P/E
Book Value ₹ -16.4
Dividend Yield 0.00 %
ROCE -83.0 %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -14.3% over past five years.
Promoter holding is low: 30.8%
Debtor days have increased from 57.4 to 95.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	6.38	1.40	4.07	1.33	4.26	7.82	9.28	6.28	4.83	1.94	2.53	4.33	3.31
	5.54	2.05	4.84	2.48	5.06	7.31	9.08	6.17	5.39	2.19	4.12	4.53	4.86
Operating Profit	0.84	-0.65	-0.77	-1.15	-0.80	0.51	0.20	0.11	-0.56	-0.25	-1.59	-0.20	-1.55
OPM %	13.17%	-46.43%	-18.92%	-86.47%	-18.78%	6.52%	2.16%	1.75%	-11.59%	-12.89%	-62.85%	-4.62%	-46.83%
	0.01	0.01	0.01	0.01	0.01	0.01	0.12	0.01	-1.17	0.01	0.01	0.01	0.03
Interest	0.05	0.12	0.18	0.16	0.16	0.11	0.13	0.11	0.24	0.28	0.24	0.28	0.50
Depreciation	0.47	0.42	0.43	0.45	0.41	0.40	0.40	0.41	-0.18	0.24	0.26	0.27	0.25
Profit before tax	0.33	-1.18	-1.37	-1.75	-1.36	0.01	-0.21	-0.40	-1.79	-0.76	-2.08	-0.74	-2.27
Tax %	48.48%	0.00%	0.00%	0.00%	6.62%	0.00%	0.00%	0.00%	-16.76%	0.00%	0.00%	0.00%	-74.45%
	0.17	-1.18	-1.37	-1.75	-1.45	0.01	-0.22	-0.39	-1.49	-0.76	-2.08	-0.73	-0.58
EPS in Rs	0.45	-3.15	-3.66	-4.68	-3.88	0.03	-0.59	-1.04	-3.98	-2.03	-5.56	-1.95	-1.55
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.00	0.00	0.00	11.89	11.99	20.92	26.17	18.24	15.39	11.02	28.20	12.11
	0.02	0.05	0.05	10.81	10.88	19.15	22.74	15.67	13.14	14.39	27.94	15.75
Operating Profit	-0.02	-0.05	-0.05	1.08	1.11	1.77	3.43	2.57	2.25	-3.37	0.26	-3.64
OPM %				9.08%	9.26%	8.46%	13.11%	14.09%	14.62%	-30.58%	0.92%	-30.06%
	0.06	0.06	0.06	0.05	0.05	0.10	0.09	0.06	0.04	0.05	-1.03	0.05
Interest	0.00	0.00	0.00	0.04	0.03	0.13	0.37	0.39	0.37	0.62	0.59	1.24
Depreciation	0.00	0.00	0.00	1.09	1.03	1.01	1.94	1.93	1.88	1.71	1.03	1.01
Profit before tax	0.04	0.01	0.01	0.00	0.10	0.73	1.21	0.31	0.04	-5.65	-2.39	-5.84
Tax %	25.00%	200.00%	100.00%		20.00%	41.10%	38.02%	54.84%	375.00%	1.77%	-12.55%	-28.94%
	0.02	0.00	-0.01	0.00	0.08	0.43	0.75	0.14	-0.10	-5.75	-2.09	-4.16
EPS in Rs	0.05	0.00	-0.03	0.00	0.21	1.15	2.00	0.37	-0.27	-15.37	-5.59	-11.12
Dividend Payout %	0.00%		0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	-14%
3 Years:	-8%
TTM:	-57%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-308%

Stock Price CAGR
10 Years:	%
5 Years:	-3%
3 Years:	25%
1 Year:	53%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.03	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45
Reserves	0.12	0.11	0.10	0.11	0.18	0.61	1.37	1.51	1.40	-4.35	-6.44	-10.60
	0.79	0.46	1.02	1.96	5.52	5.26	5.89	5.18	5.37	5.91	7.71	11.52
	0.04	0.06	2.14	10.11	9.56	10.75	11.01	6.83	6.39	9.32	13.03	22.68
Total Liabilities	4.98	5.08	7.71	16.63	19.71	21.07	22.72	17.97	17.61	15.33	18.75	28.05
	2.53	2.53	2.72	5.86	4.92	9.64	10.84	10.44	9.50	9.27	7.97	7.86
CWIP	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.10	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.20	0.20	0.20	0.00	0.00	0.00	0.40	0.40
	2.45	2.55	4.99	10.77	11.26	11.23	11.68	7.53	8.11	5.96	10.38	19.79
Total Assets	4.98	5.08	7.71	16.63	19.71	21.07	22.72	17.97	17.61	15.33	18.75	28.05

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0.06	0.00	-0.50	3.88	0.92	2.82	3.53	0.75	0.33	-0.20	-0.96	-2.36
	0.00	0.00	-0.19	-4.23	-3.41	-2.40	-3.15	-1.53	-0.94	-1.59	-0.70	-0.90
	0.00	0.10	0.56	1.14	3.10	-0.23	0.40	-0.91	-0.04	1.43	1.40	3.81
Net Cash Flow	-0.06	0.09	-0.14	0.79	0.61	0.20	0.78	-1.69	-0.65	-0.36	-0.26	0.56
Free Cash Flow	-0.06	0.00	-0.69	-0.35	-2.49	0.42	0.38	-0.78	-0.61	-1.79	-1.66	-3.26
CFO/OP	300%	0%	1,000%	359%	83%	159%	103%	29%	15%	6%	-369%	65%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days				60.48	35.01	57.58	23.01	13.61	14.70	60.28	16.57	95.24
Inventory Days				203.34	278.66	88.17	107.27	154.80	286.55	123.74	56.09	290.01
Days Payable				609.39	645.07	311.84	269.40	299.82	309.82	382.60	173.18	529.77
Cash Conversion Cycle				-345.57	-331.40	-166.09	-139.12	-131.41	-8.57	-198.58	-100.52	-144.52
Working Capital Days				-59.86	-71.84	-56.18	-48.26	-36.02	-0.47	-115.59	-40.38	-200.43
ROCE %	0.81%	0.20%	0.19%	0.66%	1.56%	8.40%	14.34%	6.13%	3.67%	-58.39%	-12.45%	-82.96%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Asset Status/Utilization Indicator (Revenue from Operations)
Rupees in Lacs

x.xx	x.xx	x.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
x.xx	x.xx	x.xx	xxx.xx	xxx.xx	x,xxx.xx	x,xxx.xx	xxx.xx	xxx.xx	xxx.xx	x,xxx.xx
x.xx	x.xx	x.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx
	x		xxx	xxx	xx	xx	xx	xx	xx	xx
											x.xx

Please log in to see hidden values.

Cost of Materials Consumed
Rupees in Lacs

Revenue from Labour Job Work
Rupees in Lacs

Employee Strength (On-Roll)
Number

Target New Product Launches
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	30.80%	30.80%	30.80%	30.83%	30.80%	30.80%	30.80%	30.80%	30.80%	30.80%	30.80%	30.80%
	69.20%	69.19%	69.19%	69.16%	69.19%	69.20%	69.20%	69.20%	69.21%	69.21%	69.20%	69.21%
No. of Shareholders	1,978	1,973	2,002	2,099	2,185	2,246	2,334	2,356	2,377	2,399	2,393	2,388

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	29.15%	30.80%	30.80%	30.80%	30.80%	30.80%	30.80%	30.83%	30.80%	30.80%
	70.85%	69.20%	69.20%	69.20%	69.20%	69.20%	69.19%	69.16%	69.20%	69.21%
No. of Shareholders	795	799	795	791	930	1,551	1,997	2,099	2,356	2,388

Documents

Announcements

All

Parmax Pharma Ltd

Parmax Pharma Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports